newsfilter
← Latest News
GlobeNewswire·

Magenta Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to